Pulmonary arterial hypertension (PAH) is a complex and devastating disease with a poor
long-term prognosis. While women are at increased risk for developing PAH, they exhibit …

Rationale: Recent studies have focused on the role of female sex and estradiol (E2) in
pulmonary arterial hypertension (PAH), but it is not known whether sex hormones are risk …

Increased oestrogen is a strong epidemiological risk factor for development of pulmonary
arterial hypertension (PAH) in patients, associated with metabolic defects. In addition …

When I was looking for a research project to pursue as a fellow in 2006, I became interested
in sex differences in pulmonary arterial hypertension (PAH). When I proposed the idea of …

Although the incidence of pulmonary hypertension is higher in female patients, numerous
experimental studies have demonstrated better outcome in female animals, exacerbation of …

Even though pulmonary arterial hypertension (PAH) is more prevalent in women, women
with PAH exhibit better right ventricular (RV) function, more favorable RV treatment …

The biology of pulmonary arterial hypertension (PAH) is full of mysteries, and one of its
longer-standing ones has also intrigued and inspired both scientists and artists throughout …

Most subtypes of pulmonary arterial hypertension (PAH) are characterized by a greater
susceptibility to disease among females, although females with PAH appear to live longer …

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by pulmonary
vascular remodeling of the distal pulmonary vasculature, ultimately leading to destruction …

Idiopathic pulmonary arterial hypertension (IPAH) is a rare but devastating disease that is
characterized by progressive elevation of the pulmonary pressures and, if untreated, leads …